(Q46853931)

English

Usefulness of prostate-specific antigen (PSA) rise as a marker of prostate cancer in men treated with dutasteride: lessons from the REDUCE study

scientific article published on 23 June 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21699645

Usefulness of prostate-specific antigen (PSA) rise as a marker of prostate cancer in men treated with dutasteride: lessons from the REDUCE study (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21699645

1 reference

based on heuristic

inferred from title

4

object named as

Mark Emberton

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

Francesco Montorsi

6

object named as

Francesco Montorsi

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21699645

author name string

Michael Marberger

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21699645

Stephen J Freedland

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21699645

Gerald L Andriole

3

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21699645

Curtis Pettaway

5

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21699645

Claudio Teloken

7

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21699645

Roger S Rittmaster

8

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21699645

Matthew C Somerville

9

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21699645

Ramiro Castro

10

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21699645

publication date

23 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21699645

BJU International

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21699645

109

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21699645

8

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21699645

1162-1169

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21699645

Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial. PLESS Study Group. Proscar Long-term Efficacy and Safety Stud

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10373.X

21 January 2018

Effect of the dual 5alpha-reductase inhibitor dutasteride on markers of tumor regression in prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10373.X

21 January 2018

Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention Trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10373.X

21 January 2018

Chemoprevention of prostate cancer in men at high risk: rationale and design of the reduction by dutasteride of prostate cancer events (REDUCE) trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10373.X

21 January 2018

Effect of dutasteride on the risk of prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10373.X

21 January 2018

An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10373.X

21 January 2018

Biopsy misidentification identified by DNA profiling in a large multicenter trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10373.X

21 January 2018

The interpretation of serum prostate specific antigen in men receiving 5alpha-reductase inhibitors: a review and clinical recommendations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10373.X

21 January 2018

Identifiers

10.1111/J.1464-410X.2011.10373.X

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21699645

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21699645

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46853931&oldid=2134751394"